BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 31978901)

  • 1. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 3. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
    Mei D; Luo Y; Wang Y; Gong J
    Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
    Zhao HY; Su YX; Zhang LH; Fu P
    Neoplasma; 2022 Jan; 69(1):233-241. PubMed ID: 34779641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
    Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
    Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
    Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ
    Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
    Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
    Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.
    Li X; Chen J; Zhang C; Han Z; Zheng X; Cao D
    BMC Pulm Med; 2023 Sep; 23(1):339. PubMed ID: 37697337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules.
    Wu YJ; Liu YC; Liao CY; Tang EK; Wu FZ
    Sci Rep; 2021 Jan; 11(1):66. PubMed ID: 33462251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
    Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
    Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer.
    Zhang L; Chen B; Liu X; Song J; Fang M; Hu C; Dong D; Li W; Tian J
    Transl Oncol; 2018 Feb; 11(1):94-101. PubMed ID: 29216508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
    Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
    Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
    Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
    Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
    Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
    Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
    Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
    Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma.
    Liu Q; Huang Y; Chen H; Liu Y; Liang R; Zeng Q
    BMC Cancer; 2020 Jun; 20(1):533. PubMed ID: 32513144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.